Patient preferences targeting PCSK9 protein
Research Grant
Administered By
Duke Clinical Research Institute
Awarded By
Novartis Pharmaceuticals Corporation
Start Date
October 16, 2020
End Date
October 31, 2021
Administered By
Duke Clinical Research Institute
Awarded By
Novartis Pharmaceuticals Corporation
Start Date
October 16, 2020
End Date
October 31, 2021